{
  "id": "ed67018c34b291df",
  "title": "Genmab Announces New Data from Phase 1b / 2 EPCORE\u00ae CLL - 1 Highlighting Potential of Epcoritamab as Mon",
  "description": "20251209T014500Z",
  "content": "",
  "source": "pharmiweb.com",
  "source_url": "https://www.pharmiweb.com/press-release/2025-12-09/genmab-announces-new-data-from-phase-1b2-epcore-cll-1-highlighting-potential-of-epcoritamab-as-mon",
  "published_at": "20251209T014500Z",
  "fetched_at": "2025-12-10T00:22:54.894572+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.pharmiweb.com/press-release/2025-12-09/genmab-announces-new-data-from-phase-1b2-epcore-cll-1-highlighting-potential-of-epcoritamab-as-mon",
    "url_mobile": "",
    "title": "Genmab Announces New Data from Phase 1b / 2 EPCORE\u00ae CLL - 1 Highlighting Potential of Epcoritamab as Mon",
    "seendate": "20251209T014500Z",
    "socialimage": "https://cdn.pharmiweb.com/media/1024/1200x448-pwjobs.png",
    "domain": "pharmiweb.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}